RETRACTED: Aspects of Viral Involvement in Chronic Immune Thrombocytopenic Purpura

Mădălina Mocanu, Magda Bădescu, Manuela Ciocoiu, Oana Bădulescu

Department of Pathophysiology, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania.

DOI: 10.4236/jbise.2014.714104                

Abstract

Short Retraction Notice

This article has been retracted to straighten the academic record. In making this decision the Editorial Board follows COPE's Retraction Guidelines. The aim is to promote the circulation of scientific research by offering an ideal research publication platform with due consideration of internationally accepted standards on publication ethics. The Editorial Board would like to extend its sincere apologies for any inconvenience this retraction may have caused.

Editor guiding this retraction: Prof. Hao Lin (EiC of EIC)

The full retraction notice in PDF is preceding the original paper, which is marked "RETRACTED".

Keywords

Thrombocytopenic Purpura, Anti-Platelet Antibodies, Infections Agents, Viruses B, C, HIV, CMV

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Danaila, C. (2004) Hematologie Generala.
[2]	Harrison (2008) Principios de Medicina Interna. 15th Edition, McGraw Hill, New York, 882-884.
[3]	McMillan, R. (2007) The Pathogenesis of Chronic Immune Thrombocytopenic Purpura. Seminars in Hematology, 44, S3-S11. http://dx.doi.org/10.1053/j.seminhematol.2007.11.002
[4]	Thota, S., Kistangari, G., Daw, H. and Spiro, T. (2012) Immune Thrombocytopenia in Adults: An Update. Cleveland Clinic Journal of Medicine, 79, 641-650. http://dx.doi.org/10.3949/ccjm.79a.11027
[5]	Anoop, P. (2012) Immune Thrombocytopenic Purpura: Historical Perspective, Current Status, Recent Advances and Future Directions. Indian Pediatrics, 49, 811-818. http://dx.doi.org/10.1007/s13312-012-0195-1
[6]	Provan, D. (2009) Characteristics of Immune Thrombocytopenic Purpura: A Guide for Clinical Practice. European Journal of Haematology, 71, 8-12. http://dx.doi.org/10.1111/j.1600-0609.2008.01207.x
[7]	Kuwana, M. and Ikeda, Y. (2005) The Role of Auto-reactive T-Cells in the Pathogenesis of Idiopathic Thrombocytopenic Purpura. International Journal of Hematology, 81, 106-112. http://dx.doi.org/10.1532/IJH97.04176
[8]	Cines, D.B., Liebman, H. and Stasi, R. (2009) Pathobiology of Secondary Immune Thrombocytopenia. Seminars in Hematology, 46, S2-S14. http://dx.doi.org/10.1053/j.seminhematol.2008.12.005
[9]	McCrae, K. (2011) Immune Thrombocytopenia: No Longer “Idiopathic”. Cleveland Clinic Journal of Medicine, 78, 358-373. http://dx.doi.org/10.3949/ccjm.78gr.10005
[10]	Laboratory Corporation of America. Directory of Services and Interpretive Guide (2010) Platelet Autoantibody Panel, Whole Blood. Platelet Antibody Profile, Serum. https://www.labcorp.com/wps/portal/
[11]	Laborator Synevo (2010) Referintele specifice tehnologiei de lucru utilizate. https://www.synevo.ro/anticorpi-antitrombocitari-liberi-in-ser/
[12]	Laborator Synevo (2010) Referintele specifice tehnologiei de lucru utilizate 2010. https://www.synevo.ro/anti-hcv/
[13]	Laborator Synevo (2010) Referintele specifice tehnologiei de lucru utilizate 2010. https://www.synevo.ro/ag-hbs/
[14]	Laborator Synevo (2010) Referintele specifice tehnologiei de lucru utilizate 2010. https://www.synevo.ro/anti-hiv12/
[15]	Laborator Synevo (2010) Referintele specifice tehnologiei de lucru utilizate 2010. https://www.synevo.ro/citomegalovirus-anticorpi-igg/